Closing the Scale-Up Gap: N-1 Perfusion Strategies for Commercial-Ready Biologics (FREE Webinar)

FREE Webinar • Wednesday, August 27, 2025 • 11:00 AM ET

Scaling a biologic from development to commercial production often exposes cracks in upstream process design — especially when traditional seed trains, media prep capacity, or facility layout can’t support higher-volume output. This “scale-up gap” can delay tech transfer, increase batch failure risk, and force trade-offs between productivity and flexibility.

In this webinar, Boehringer Ingelheim BioXcellence™ shares how modular N‑1 perfusion strategies can be integrated into existing fed-batch platforms to address these constraints. You’ll learn how this approach improves inoculum density, shortens seed train timelines, and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.

Key Learning Objectives
• Identify common scale-up constraints in upstream biologics manufacturing — and how N‑1 perfusion helps resolve them
• Understand how modular N‑1 perfusion can improve inoculum density, seed train speed, and overall process reliability
• Learn key facility-fit and tech transfer considerations for implementing perfusion strategies at commercial scale